Search Results - Pollock RF
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling appr... by Pollock RF, Chubb B, Valentine WJ, Heller S
Published in Diabetes, Metabolic Syndrome and Obesity (2018-05-01)Get full text
Article -
5
Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden by Cardell LO, Sterner T, Ahmed W, Slættanes AK, Svärd M, Pollock RF
Published in ClinicoEconomics and Outcomes Research (2024-06-01)Get full text
Article -
6
Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain by Merino-Torres JF, Ilham S, Alshannaq H, Pollock RF, Ahmed W, Norman GJ
Published in ClinicoEconomics and Outcomes Research (2024-11-01)Get full text
Article -
7
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia by Hadzi Boskovic D, Smith-Palmer J, Pöhlmann J, Pollock RF, Hwang S, Bruhn D
Published in Patient Related Outcome Measures (2024-06-01)Get full text
Article -
8
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China by Hu S, Wu D, Wu J, Zhang Y, Bøgelund M, Pöhlmann J, Pollock RF
Published in Patient Related Outcome Measures (2023-09-01)Get full text
Article
